Mirati Ther Stock Revenue
Mirati Ther fundamentals help investors to digest information that contributes to Mirati Ther's financial success or failures. It also enables traders to predict the movement of Mirati Stock. The fundamental analysis module provides a way to measure Mirati Ther's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mirati Ther stock.
Mirati |
Mirati Ther Company Revenue Analysis
Mirati Ther's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Mirati Ther Revenue | 12.44 M |
Most of Mirati Ther's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mirati Ther is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Mirati Ther reported 12.44 M of revenue. This is 99.84% lower than that of the Biotechnology sector and 98.33% lower than that of the Health Care industry. The revenue for all United States stocks is 99.87% higher than that of the company.
Mirati Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mirati Ther's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mirati Ther could also be used in its relative valuation, which is a method of valuing Mirati Ther by comparing valuation metrics of similar companies.Mirati Ther is currently under evaluation in revenue category among its peers.
Mirati Fundamentals
| Return On Equity | -0.7 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (10.49) % | |||
| Current Valuation | 3.19 B | |||
| Shares Outstanding | 70.15 M | |||
| Shares Owned By Insiders | 1.72 % | |||
| Shares Owned By Institutions | 98.28 % | |||
| Number Of Shares Shorted | 4.39 M | |||
| Price To Earning | (3.97) X | |||
| Price To Book | 4.35 X | |||
| Price To Sales | 107.82 X | |||
| Revenue | 12.44 M | |||
| Gross Profit | (519.79 M) | |||
| EBITDA | (759.59 M) | |||
| Net Income | (740.87 M) | |||
| Cash And Equivalents | 1.19 B | |||
| Cash Per Share | 21.41 X | |||
| Total Debt | 51.51 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 10.10 X | |||
| Book Value Per Share | 13.50 X | |||
| Cash Flow From Operations | (570.57 M) | |||
| Short Ratio | 2.88 X | |||
| Earnings Per Share | (12.18) X | |||
| Target Price | 61.2 | |||
| Number Of Employees | 587 | |||
| Beta | 0.77 | |||
| Market Capitalization | 4.12 B | |||
| Total Asset | 1.2 B | |||
| Retained Earnings | (2.45 B) | |||
| Working Capital | 949.51 M | |||
| Current Asset | 125.4 M | |||
| Current Liabilities | 9.8 M | |||
| Z Score | 43.99 | |||
| Net Asset | 1.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |